0202607150648

Cochrane Patient and Public Network Executive's Strategy 2027–2032 Description: This Cochrane Patient and Public Network Executive's (PPI) Strategy updates the five-year plan developed in 2022, and will guide the Network's actions for 2027–2032. The current draft (Version 6, 11 November 2026) was informed by a global public survey (258 responses, reported from 62 countries, open 11 November – 19 December 2025, thematic analysis completed February 2026), ongoing co-design activities, and comments made by patients, members of the public and researchers at two public feedback webinars (23 July 2026) and by email. Webinar comments were treated as a data source for the November 2026 revision: they are recorded anonymously in Appendix A of the draft, and points in the Strategy that were added, changed or sharpened because of them carry a reference to the comment concerned. Drafting was done openly in a shared working document, through successive versions commented on by the whole Executive between February and November 2026.
STARDIT ID: 0202607150648

Dates

State ongoing
Start 2026-02-03
Form updated 2026-11-11

Location

Global

Aims

guide the Network's actions for 2027–2032, informed by patient and public survey feedback, public feedback webinars and co-design

Category

policy

Inputs

group of individuals

Survey respondents (258)

---

Task: Completed survey
Compensation: volunteer

group of individuals

Patients, members of the public and researchers attending the public feedback webinars

---

Task: Discussed an earlier draft of the Strategy at two public feedback webinars (23 July 2026) and submitted comments by email | comments were anonymised and used as a data source for the November 2026 revision
Compensation: volunteer

group of individuals

Cochrane

---

Task: Administrative support and oversight
Compensation: volunteer

group of individuals

Cochrane Patient and Public Involvement Network Executive (7)

---

Task: Drafted initial survey, analysed data, co-created the draft strategy summary, facilitated the public feedback webinars and revised the Strategy in response to feedback
Compensation: volunteer

other resources

---

Cochrane Staff time

---

Staff time contributed by Cochrane to develop, co-design, survey, analyse and draft the Strategy.

time

---

40 hours

---

Volunteer time contributed by members of the Cochrane Patient and Public Involvement Executive to develop, co-design and draft the Strategy.

other resources

---

AI assistance

---

AI assistance was used for parts of the drafting, formatting and summarising of the Strategy document. AI-assisted changes are labelled in the tracked version so readers can see them, and all content has been reviewed by members of the Executive, who remain responsible for it. Recorded in line with Cochrane's guidance on the transparent use of AI.

Outputs and impacts

publication/report/document

State: Completed

Thematic analysis of global survey responses (link)

---

---

Global survey of patients, public, Cochrane authors/groups and evidence-community members (258 responses, reported from 62 countries; open 11 Nov–19 Dec 2025). Reports themes on barriers to involvement (time, awareness, disconnection, confidence, compensation, language) and top-ranked values (inclusivity & representation, transparency & openness, accessibility, equity, impact).

publication/report/document

State: Completed

Draft summary of the Strategy (link)

---

---

Draft summary of the Strategy, informed by the survey above and co-design activities, shared for public feedback ahead of two webinars (23 July 2026) and finalisation.

publication/report/document

State: Completed

Draft Strategy 2027–2032 (Version 6, 11 November 2026)

---

---

Full draft Strategy prepared for the Cochrane Board and for discussion at the Patient and Public Network Executive's workshop at the Cochrane Colloquium, Kraków, December 2026. Includes a plain language summary, priority short-term actions (0–24 months), priority long-term initiatives (24 months–5 years), values, a risks and safeguards section, three open questions for the workshop, Appendix A (anonymised record of public feedback webinar comments, plus notes on the reliability of those sources) and Appendix B (principles for the payment pilot). Points shaped by public feedback are referenced to the anonymised comments in Appendix A.

publication/report/document

State: Prospective

Final Cochrane Patient and Public Involvement Strategy 2027–2032

---

---

Final Strategy, to be published after further public involvement, including the Cochrane Colloquium workshop in Kraków (December 2026) and Board consideration.

STARDIT report information

STARDIT report authors

Jack Nunn
0000-0003-0316-3254
Created report